These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31918023)

  • 21. The osteoclast, bone remodelling and treatment of metabolic bone disease.
    Boyce BF; Rosenberg E; de Papp AE; Duong LT
    Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence.
    Wong SK; Mohamad NV; Ibrahim N'; Chin KY; Shuid AN; Ima-Nirwana S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH is a negative regulator of skeletal remodeling.
    Abe E; Marians RC; Yu W; Wu XB; Ando T; Li Y; Iqbal J; Eldeiry L; Rajendren G; Blair HC; Davies TF; Zaidi M
    Cell; 2003 Oct; 115(2):151-62. PubMed ID: 14567913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
    Gilbert LC; Chen H; Lu X; Nanes MS
    Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone cells, bone metabolism and cGMP.
    Howard GA
    Prog Clin Biol Res; 1985; 187():67-76. PubMed ID: 2997799
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone remodelling and its regulators].
    Yoshikawa H; Takaoka K
    Nihon Rinsho; 1994 Sep; 52(9):2262-7. PubMed ID: 7967065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice.
    Pereira M; Jeyabalan J; Jørgensen CS; Hopkinson M; Al-Jazzar A; Roux JP; Chavassieux P; Orriss IR; Cleasby ME; Chenu C
    Bone; 2015 Dec; 81():459-467. PubMed ID: 26314515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
    Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
    J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblastic responses to TGF-beta during bone remodeling.
    Erlebacher A; Filvaroff EH; Ye JQ; Derynck R
    Mol Biol Cell; 1998 Jul; 9(7):1903-18. PubMed ID: 9658179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mathematical model of bone remodelling cycles for trabecular bone at the cellular level.
    Ji B; Genever PG; Patton RJ; Putra D; Fagan MJ
    Biomech Model Mechanobiol; 2012 Sep; 11(7):973-82. PubMed ID: 22218996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies.
    Lemaire V; Cox DR
    Bull Math Biol; 2019 Sep; 81(9):3575-3622. PubMed ID: 30460589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Janus kinase inhibitors role in bone remodeling.
    Maruotti N; Corrado A; Rotondo C; Cantatore FP
    J Cell Physiol; 2020 Mar; 235(3):1915-1920. PubMed ID: 31486093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New mechanisms and targets in the treatment of bone fragility.
    Martin TJ; Seeman E
    Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current Topics on Vitamin D. The role of active forms of vitamin D in regulation of bone remodeling].
    Nakamichi Y; Takahashi N
    Clin Calcium; 2015 Mar; 25(3):395-402. PubMed ID: 25716813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging of the Bone.
    Wei Y; Sun Y
    Adv Exp Med Biol; 2018; 1086():189-197. PubMed ID: 30232760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amylin and adrenomedullin: novel regulators of bone growth.
    Cornish J; Naot D
    Curr Pharm Des; 2002; 8(23):2009-21. PubMed ID: 12171515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating treatment of osteoporosis using particle swarm on a bone remodelling mathematical model.
    Chen AB; Zhang P; Yokota H
    IET Syst Biol; 2013 Dec; 7(6):231-42. PubMed ID: 24712100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis.
    Pierotti S; Gandini L; Lenzi A; Isidori AM
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):292-9. PubMed ID: 17950597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupling factors and exosomal packaging microRNAs involved in the regulation of bone remodelling.
    Zhu S; Yao F; Qiu H; Zhang G; Xu H; Xu J
    Biol Rev Camb Philos Soc; 2018 Feb; 93(1):469-480. PubMed ID: 28795526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.